Bill > H330

This bill updates North Carolina's Controlled Substances Act by making several technical amendments to categorize and regulate various drug compounds. Specifically, the bill adds numerous synthetic opioid derivatives like AP-237, U-47700, and various chemical variations to Schedule I, expanding the list of controlled substances. It introduces a new category of "Nitazene derivatives" - a class of synthetic opioids with complex chemical structures derived from benzimidazole, which are now regulated. The bill also modifies descriptions of fentanyl derivatives, clarifying chemical names and adding alternative nomenclature for specific compounds. Additionally, the legislation updates regulations on synthetic cannabinoids by broadening definitions and adding new chemical variants like MDMB-ICA and several indole, indazole, and oxindole-based compounds. The bill makes minor technical corrections to spelling and chemical nomenclature for certain substances, such as correcting "Dehydrochlormethyltestosterone" to "Dehydrochloromethyltestosterone" and "Mesterolene" to "Mesterolone". These changes aim to keep drug laws current with emerging synthetic substances and close potential legal loopholes in drug classification.

Government Affairs, Justice

https://www.ncleg.gov/BillLookUp/2025/H330